Ebtehal El‐Demerdash

1.0k total citations
25 papers, 771 citations indexed

About

Ebtehal El‐Demerdash is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Ebtehal El‐Demerdash has authored 25 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Ebtehal El‐Demerdash's work include Chemotherapy-induced organ toxicity mitigation (8 papers), Reproductive Biology and Fertility (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Ebtehal El‐Demerdash is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (8 papers), Reproductive Biology and Fertility (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Ebtehal El‐Demerdash collaborates with scholars based in Egypt, Saudi Arabia and United States. Ebtehal El‐Demerdash's co-authors include Samira Saleh, Noha M. Saeed, Hanaa M. Abdel-Rahman, Ashraf B. Abdel‐Naim, Eman M. Mantawy, Reem N. El‐Naga, Samar S. Azab, Fahad A. Al‐Abbasi, Mardi M. Algandaby and Wesam M. El‐Bakly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ebtehal El‐Demerdash

25 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ebtehal El‐Demerdash Egypt	15	278	195	127	113	98	25	771
Tawar Qaradakhi Australia	15	214 0.8×	356 1.8×	116 0.9×	70 0.6×	95 1.0×	23	1.1k
Aziz Karaoğlu Türkiye	11	354 1.3×	174 0.9×	68 0.5×	106 0.9×	133 1.4×	47	966
Marwa M. Khalaf Egypt	14	212 0.8×	235 1.2×	70 0.6×	80 0.7×	60 0.6×	42	714
M.L.P. Bianchi Brazil	12	386 1.4×	251 1.3×	58 0.5×	87 0.8×	130 1.3×	19	800
Hany M. Abo‐Haded Egypt	12	144 0.5×	160 0.8×	153 1.2×	45 0.4×	61 0.6×	30	576
El‐Sayed M. El‐Sayed Egypt	16	154 0.6×	118 0.6×	71 0.6×	44 0.4×	68 0.7×	29	694
Kezhen Shen China	14	231 0.8×	195 1.0×	50 0.4×	47 0.4×	98 1.0×	18	777
Eman M. Mantawy Egypt	17	127 0.5×	234 1.2×	209 1.6×	76 0.7×	144 1.5×	27	817
Petra Miketová United States	18	138 0.5×	339 1.7×	78 0.6×	74 0.7×	45 0.5×	24	874
Fares E.M. Ali Egypt	22	295 1.1×	389 2.0×	53 0.4×	134 1.2×	115 1.2×	68	1.1k

Countries citing papers authored by Ebtehal El‐Demerdash

Since Specialization

Citations

This map shows the geographic impact of Ebtehal El‐Demerdash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebtehal El‐Demerdash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebtehal El‐Demerdash more than expected).

Fields of papers citing papers by Ebtehal El‐Demerdash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebtehal El‐Demerdash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebtehal El‐Demerdash. The network helps show where Ebtehal El‐Demerdash may publish in the future.

Co-authorship network of co-authors of Ebtehal El‐Demerdash

This figure shows the co-authorship network connecting the top 25 collaborators of Ebtehal El‐Demerdash. A scholar is included among the top collaborators of Ebtehal El‐Demerdash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebtehal El‐Demerdash. Ebtehal El‐Demerdash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elsherbiny, Doaa A., et al.. (2025). Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways. BMC Pharmacology and Toxicology. 26(1). 81–81. 1 indexed citations

Said, Riham S., et al.. (2024). Hesperidin attenuates radiation-induced ovarian failure in rats: Emphasis on TLR-4/NF-ĸB signaling pathway. Toxicology and Applied Pharmacology. 492. 117111–117111. 5 indexed citations

Michel, Haidy E., et al.. (2024). Coenzyme Q10 ameliorates cyclophosphamide-induced chemobrain by repressing neuronal apoptosis and preserving hippocampal neurogenesis: Mechanistic roles of Wnt/ β-catenin signaling pathway. NeuroToxicology. 105. 21–33. 6 indexed citations

Michel, Haidy E., et al.. (2022). The Cannabinoid-2 receptor agonist, 1-phenylisatin, protects against cisplatin-induced nephrotoxicity in mice. Life Sciences. 308. 120928–120928. 8 indexed citations

Tolba, Mai F., et al.. (2021). Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling. Clinical and Experimental Pharmacology and Physiology. 48(10). 1358–1370. 9 indexed citations

El‐Bakly, Wesam M., et al.. (2021). Effect of Viscum album extract on angiogenesis mediators and cytokines in Egyptian patients with intermediate hepatocellular carcinoma. SHILAP Revista de lepidopterología. 5(1). 33–45. 1 indexed citations

Mantawy, Eman M., et al.. (2019). Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(4). 739–748. 33 indexed citations

Said, Riham S., Eman M. Mantawy, & Ebtehal El‐Demerdash. (2019). Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(10). 1225–1238. 42 indexed citations

El‐Bakly, Wesam M., et al.. (2015). Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity. Cancer Chemotherapy and Pharmacology. 77(2). 309–322. 11 indexed citations

10.

Mahran, Yasmen F., Ebtehal El‐Demerdash, Ahmed S. Nada, et al.. (2015). Growth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis. PLoS ONE. 10(10). e0140055–e0140055. 18 indexed citations

11.

Saeed, Noha M., et al.. (2015). Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study. Biochemical Pharmacology. 95(3). 145–155. 92 indexed citations

12.

Azab, Samar S., et al.. (2013). Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sciences. 92(10). 555–561. 30 indexed citations

13.

Ghadami, Mohsen, Ebtehal El‐Demerdash, Dong Zhang, et al.. (2012). Bone Marrow Transplantation Restores Follicular Maturation and Steroid Hormones Production in a Mouse Model for Primary Ovarian Failure. PLoS ONE. 7(3). e32462–e32462. 34 indexed citations

14.

Saeed, Noha M., Ebtehal El‐Demerdash, Hanaa M. Abdel-Rahman, et al.. (2012). Anti-inflammatory activity of methyl palmitate and ethyl palmitate in different experimental rat models. Toxicology and Applied Pharmacology. 264(1). 84–93. 128 indexed citations

15.

Saleh, Samira, et al.. (2009). Protective Effects of the Angiotensin II Receptor Blocker Losartan on Cisplatin-Induced Kidney Injury. Chemotherapy. 55(6). 399–406. 68 indexed citations

16.

Azab, Samar S., Salama A. Salama, Ashraf B. Abdel‐Naim, et al.. (2008). 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?. Breast Cancer Research and Treatment. 113(1). 9–19. 15 indexed citations

17.

El‐Demerdash, Ebtehal, et al.. (2007). INHIBITION OF THE RENIN–ANGIOTENSIN SYSTEM ATTENUATES THE DEVELOPMENT OF LIVER FIBROSIS AND OXIDATIVE STRESS IN RATS. Clinical and Experimental Pharmacology and Physiology. 35(2). 159–167. 19 indexed citations

18.

Saleh, Samira & Ebtehal El‐Demerdash. (2005). Protective Effects of L‐Arginine against Cisplatin‐Induced Renal Oxidative Stress and Toxicity: Role of Nitric Oxide. Basic & Clinical Pharmacology & Toxicology. 97(2). 91–97. 111 indexed citations

19.

El‐Demerdash, Ebtehal, et al.. (2004). Probucol attenuates oxidative stress and energy decline in isoproterenol-induced heart failure in rat. Pharmacological Research. 51(4). 311–318. 28 indexed citations

20.

Osman, Abdel‐Moneim M., et al.. (2000). PREVENTION OF CISPLATIN-INDUCED NEPHROTOXICITY BY METHIMAZOLE. Pharmacological Research. 41(1). 113–119. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact